Benchmark Financial Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$652K Sell
1,801
-26
-1% -$8.9K 0.16% 71
2026
Q1
$643K Buy
1,827
+496
+37% +$177K 0.18% 67
2025
Q4
$436K Buy
1,331
+476
+56% +$151K 0.13% 82
2025
Q3
$241K Sell
855
-50
-6% -$14.5K 0.07% 101
2025
Q2
$253K Buy
905
+132
+17% +$37.4K 0.08% 96
2025
Q1
$241K Buy
773
+3
+0.4% +$886 0.09% 90
2024
Q4
$201K Sell
770
-392
-34% -$116K 0.06% 99
2024
Q3
$374K Sell
1,162
-35
-3% -$11.4K 0.12% 68
2024
Q2
$374K Sell
1,197
-154
-11% -$45.2K 0.14% 60
2024
Q1
$384K Buy
1,351
+215
+19% +$62.9K 0.15% 57
2023
Q4
$327K Buy
1,136
+119
+12% +$32.4K 0.14% 60
2023
Q3
$273K Buy
+1,017
New +$254K 0.13% 57

Other funds holding AMGN

Benchmark Financial Wealth Advisors's AMGN Position: Q2 2026 in Review

Benchmark Financial Wealth Advisors reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $8.9K and leaving 1,801 shares worth $652K. The position accounts for 0.16% of the portfolio, ranked #71.

Benchmark Financial Wealth Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Benchmark Financial Wealth Advisors held 1,801 shares of Amgen worth $652K as of Q2 2026.
  • Benchmark Financial Wealth Advisors sold 26 Amgen shares in Q2 2026, an estimated $8.9K.
  • Amgen made up 0.16% of Benchmark Financial Wealth Advisors's portfolio in Q2 2026, its #71 holding.
  • Benchmark Financial Wealth Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Benchmark Financial Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.